Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

JBS N.V. (JBS) SEC Filings & Earnings Calls

EquiReason read 26 JBS N.V. SEC filings in the last 12 months. Latest: 8-K on 2026-09-15 — JBS N.V. filed an 8-K with only Item 9.01 (financial statements and exhibits) and no substantive Item 8.01 disclosure. The filing contains only a cover page exhibit. No material ev.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

Packaged Foods · Consumer Defensive
—
Price chart with a free account
Market cap
13.8B
P/E TTM
11.6
Dividend yield
7.5%
52-week
—
Next earnings
9 Nov, in 16 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

15 Sep 20268-K · 8.01JBS N.V. filed an 8-K with only Item 9.01 (financial statements and exhibits) and no substantive Item 8.01 disclosure. The filing contains only a cover page exhibit. No material event.SEC ↗
19 Aug 20268-K · 7.01, 8.01JBS N.V. proposes to acquire remaining ~18% of Pilgrim's Pride shares not already owned, offering 2.086 JBS shares per PPC share. Transaction subject to special committee and unaffiliated shareholder approval.acquisitionopen

Figures in the filing · each found in the filing text

Exchange ratio · Q3-2026$2.09
JBS closing share price · August 18, 2026$13.66
PPC closing share price · August 18, 2026$28.49

Risks flagged

Transaction subject to approval by special committee and unaffiliated shareholders; may not close.

“Subject to approval of independent special committee of PPC board and majority of unaffiliated PPC shares; non-binding proposal”
Read the original on SEC EDGAR ↗
11 Aug 20268-K · 2.02, 5.02, 7.01Net Sales $23.90B (+14% y/y); Adjusted EBITDA (IFRS) $1.43B (-18% y/y); Net Income Attributable to JBS $-102Mearningsopen

Figures in the filing · each found in the filing text

Net Sales · Q2-2026$23.90B+14% y/y
Adjusted EBITDA (IFRS) · Q2-2026$1.43B-18% y/y
Net Income Attributable to JBS · Q2-2026$-102M
Earnings Per Share · Q2-2026$-0.10
Leverage (Net Debt / Adjusted EBITDA LTM) · Q2-2026$3.10

Risks flagged

Cattle supply constraints in US due to restricted Mexican imports and low cattle availability.

“Live cattle imports from Mexico remained restricted during the quarter, further constraining supply in the U.S. market.” · word for word

Antitrust settlements and tender offer costs impacting net income.

“antitrust settlements of $133 million... $172 million in premiums, interest, and costs associated with the tender offers”

Leverage above long-term target at 3.1x.

“Leverage ended 2Q26 at 3.1x, slightly above the Company’s long-term target.” · word for word
Read the original on SEC EDGAR ↗
10 Aug 202610-QH1 2026 net income fell 87.4% YoY due to record cattle costs, margin compression, and higher finance expenses.earningsopen

Figures in the filing · each found in the filing text

Net revenue · H1-2026$45.51B+12% y/y
Net income · H1-2026$145M-87% y/y
Gross profit · H1-2026$4.91B-10% y/y
Adjusted EBITDA · H1-2026$2.56B-22% y/y
Total outstanding indebtedness · 2026-06-30$22.65B
Cash and cash equivalents, margin cash and long-term investments · 2026-06-30$3.69B
Revolving credit facility capacity · 2026-06-30$3.40B

Risks flagged

Record cattle costs

“primarily due to the increase in the cost of cattle, which reached record levels.” · word for word

High leverage and rising interest expense

“Interest expense increased by US$205.5 million, or 25.9%, in the six-month period ended June 30, 2026” · word for word

DOJ and antitrust agreement costs

“U.S. Department of Justice and antitrust agreements increased by US$23.7 million, to US$157.4 million” · word for word
Read the original on SEC EDGAR ↗
7 Aug 20266-KIndonesia sovereign fund DIM to invest USD 2.5B for 25% stake in JBS's Australia/New Zealand protein business joint venture; total capital raise up to USD 5B including debt.being acquiredopen

Figures in the filing · each found in the filing text

DIM Investment$2.50B
Total Capital Raise$5.00B

Risks flagged

Transaction subject to regulatory approvals and closing conditions; may not occur as planned.

“Completion remains subject to regulatory approvals and other customary closing conditions.”

Exchange right for DIM to convert JV stake into JBS shares could dilute existing shareholders.

“DIM has the right to exchange its JV shares for newly issued JBS shares after 6 years if no IPO.”
Read the original on SEC EDGAR ↗
5 Aug 20266-KJBS N.V. upsized global revolving credit facility to $2.65B, expanding total availability to $4.2B; strengthens liquidity position.open

Figures in the filing · each found in the filing text

Revolving credit facility amount$2.65B
Total revolver capacity$4.20B
Read the original on SEC EDGAR ↗
31 Jul 20266-KJBS N.V. files Brazilian Corporate Governance Report (CVM Resolution 80/2022) as a 6-K; no material financial or operational event disclosed.SEC ↗
15 Jun 20266-KJBS N.V. filed a 6-K to announce an investor presentation posted on its website. No material financial or operational information disclosed.SEC ↗
14 May 20266-KDividend payment notice; $1.00 per share declared, payable June 17, 2026.SEC ↗
12 May 20266-KJBS announces voluntary transition to file SEC reports as U.S. domestic company starting Q2 2026, accelerating disclosure calendar.SEC ↗
12 May 20266-KJBS N.V. filed Q1 2026 results with net revenue $21.6B, operating profit $484M, net income $242M; revenue up 10.7% YoY but profit down 45% due to cost pressures.open

Figures in the filing · each found in the filing text

Net Revenue · Q1-2026$21.61B+11% y/y
Gross Profit · Q1-2026$2.32B-11% y/y
Operating Profit · Q1-2026$484M-45% y/y
Net Income · Q1-2026$242M-57% y/y
Gross Margin · Q1-202610.8%

Risks flagged

Sharp earnings decline with margin compression; cost inflation outpacing revenue growth.

“Net income down 56.6% YoY; operating profit down 45.1%; gross margin down 260 bps.”
Read the original on SEC EDGAR ↗
30 Apr 20266-KJBS N.V. held its 2026 Annual General Meeting; all agenda items adopted including annual accounts, director reappointments, and auditor reappointment. No material financial or operational changes disclosed.open

Figures in the filing · each found in the filing text

Net Revenue · FY2025$86.00B+12% y/y
Net Income · FY2025$2.00B+13% y/y
Read the original on SEC EDGAR ↗
15 Apr 20266-KJBS N.V. filed Dutch IFRS annual report for FY2025 as part of AGM materials; no new financial results or material events.SEC ↗
13 Apr 20266-KJBS N.V. announces tender offer results and upsized cap to US$1.2B, and US$500M re-tap of 2037 & 2057 notes. Net proceeds used for tender offer and general corporate purposes. No earnings or guidance.open

Figures in the filing · each found in the filing text

aggregate principal amount of 2034 notes tendered · point_in_time$1.32B
aggregate principal amount of 2035 notes tendered · point_in_time$830M
increased maximum amount for tender · point_in_time$1.20B
additional 2037 notes principal · point_in_time$250M
additional 2057 notes principal · point_in_time$250M

Risks flagged

Increased debt may raise leverage; but refinancing extends maturities.

“Upsized tender cap and additional note issuances.”
Read the original on SEC EDGAR ↗
8 Apr 20266-KFiling is a 6-K containing agenda and explanatory notes for the 2026 Annual General Meeting. No material financial event or operational update is disclosed.SEC ↗
31 Mar 20266-KJBS prices $2B senior notes offering: $1.25B at 5.625% due 2037 and $750M at 6.400% due 2057. Proceeds to fund tender offers for existing notes and general corporate purposes.open

Figures in the filing · each found in the filing text

Notes Offering Amount · Q1-2026$2.00B

Risks flagged

Debt refinancing risk reduced; leverage remains elevated but manageable with successful pricing.

“Net proceeds used to pay consideration for tender offers of up to $1B of existing notes and for general corporate purposes.”
Read the original on SEC EDGAR ↗
27 Mar 20266-KJBS N.V. announced filing of its Annual Report on Form 20-F for FY2025 with the SEC on March 25, 2026.SEC ↗
26 Mar 20266-KJBS reports record sales in 4Q25 and FY2025, with net sales up 15% and 12% YoY respectively, but adjusted EBITDA declined 7% and 5% due to cattle cost pressure. Net income grew 1% and 15%.open

Figures in the filing · each found in the filing text

Net Sales · Q4-2025$23.06B+15% y/y
Net Sales · FY2025$86.18B+12% y/y
Adjusted EBITDA (IFRS) · Q4-2025$1.72B-7% y/y
Adjusted EBITDA (IFRS) · FY2025$6.83B-5% y/y
Net Income Attributable to JBS · Q4-2025$415M+1% y/y
Net Income Attributable to JBS · FY2025$2.02B+15% y/y
Earnings Per Share · Q4-2025$0.39+1% y/y
Earnings Per Share · FY2025$1.89+15% y/y
Free Cash Flow · Q4-2025$990M
Free Cash Flow · FY2025$400M

Risks flagged

Cattle cost inflation and supply constraints pressuring beef margins.

“increase in cattle prices outpaced the change in cutout values, reflecting tighter cattle availability amid the ongoing U.S. cattle cycle. In addition, live cattle imports from Mexico were restricted beginning in May 2025, further constraining supply in the U.S. market for much of the year.” · word for word

Temporary export restrictions due to avian influenza in Brazil.

“temporary restrictions in key markets such as China and Europe following a single avian influenza case in Brazil in May.” · word for word
Read the original on SEC EDGAR ↗
25 Mar 202620-FAnnual report (20-F) filed by JBS N.V. for FY2025, containing standard debt and covenant disclosures, capex increase, and trend information.open

Figures in the filing · each found in the filing text

Net Revenue · FY2025$86.18B+12% y/y
Net Income · FY2025$2.23B+13% y/y
Adjusted EBITDA · FY2025$6.83B-5% y/y
Adjusted EBITDA Margin · FY20257.9%
Total Outstanding Indebtedness · FY2025$21.09B
Dividend per Share · FY2025$1.00

Risks flagged

Material Weakness in Internal Controls

“We identified a material weakness in our internal controls. ... relate to ineffective design, implementation and operation of general information technology controls, or GITCs, in the areas of user access and program change-management over certain information technology systems in certain of our subsidiaries that support our financial reporting processes.” · word for word

Avian Influenza Export Disruption

“In May 2025, a single case of avian influenza was recorded in Brazil, resulting in a temporary restriction of exports to key markets such as Europe and China, impacting the revenue of our chicken exports until September and November 2025, respectively.” · word for word

Controlling Shareholder Influence

“Our ultimate controlling shareholders held 85.68% of voting power as of March 18, 2026. This significant concentration of voting rights gives them substantial influence over our company.” · word for word

Beef North America Segment Losses

“Beef North America segment had net revenue of US$28.1 billion and Adjusted EBITDA of US$(319.5) million.” · word for word

High Indebtedness

“As of December 31, 2025, our total outstanding indebtedness was US$21,090.6 million” · word for word
Read the original on SEC EDGAR ↗
17 Feb 20266-KJBS N.V. filed a 6-K attaching a CAGNY 2026 investor presentation. No material financial event or operational update is disclosed in the filing body.SEC ↗
9 Feb 20266-KJBS invests USD 150M in joint venture in Oman to establish a multiprotein hub, holding 80% stake; capacity ~300k tons/year.acquisitionopen

Figures in the filing · each found in the filing text

Investment amount$150M
Enterprise Value pre-money$168M
Production capacity$300000.00

Risks flagged

Execution risk in establishing operations in Oman and obtaining regulatory approvals

“Consummation subject to regulatory approvals; production start within 6-12 months.”
Read the original on SEC EDGAR ↗
25 Nov 20256-KJBS enters binding MOU to form JBS VIVA, a 50/50 JV with VIVA shareholders combining leather assets; JBS VIVA will process >20M hides/year with 31 factories.being acquiredopen

Figures in the filing · each found in the filing text

hides processed per year · leather · unknown20,000,000
number of factories · leather · unknown31
number of employees · leather · unknown11,000

Risks flagged

Transaction completion risk: subject to definitive documents and conditions precedent.

“The completion of the transaction is subject to the negotiation of definitive documents and other conditions precedent common to this type of transaction.” · word for word

Integration and operational risks from combining two companies' leather operations across multiple countries.

“unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies” · word for word
Read the original on SEC EDGAR ↗
21 Nov 20256-KJBS N.V. becomes successor co-issuer of 15 series of notes (total ~$15B) and borrower under revolving credit facility; JBS S.A. released as guarantor. Financial covenant changed from max debt-to-capitalization 55% to min interest coverage ropen

Figures in the filing · each found in the filing text

minimum interest coverage ratio · Q2-2026$3.00

Risks flagged

Debt covenant change reduces balance sheet risk; interest coverage test is more flexible than leverage test.

“Replaced max debt to capitalization (55%) with min interest coverage (3.00x).”
Read the original on SEC EDGAR ↗
17 Nov 20256-KJBS N.V. announces that its joint venture Mantiqueira USA has entered into a binding agreement to acquire Hickman's Egg Ranch, a top 20 US egg producer. Transaction expected to close before year-end. Strategic expansion in US egg market.being acquiredSEC ↗
13 Nov 20256-KJBS N.V. reported Q3 2025 net revenue of $63.1B (9M) vs $57.2B prior year, net income $1.79B vs $1.51B; operating profit $3.21B vs $3.41B; strong revenue growth but slight operating margin compression.open

Figures in the filing · each found in the filing text

Net Revenue · 9M-2025$63.12B+10% y/y
Net Income · 9M-2025$1.79B+19% y/y
Gross Profit · 9M-2025$8.43B-2% y/y
Operating Profit · 9M-2025$3.21B-6% y/y

Risks flagged

Gross margin pressure from input cost inflation

“Gross profit declined despite revenue growth; cost of sales increased to $54.7B from $48.6B”
Read the original on SEC EDGAR ↗
10 Nov 20256-KJBS concludes share repurchase program, repurchasing 41,008,292 shares for $600 million; efficient use of cash at comfortable leverage.open

Figures in the filing · each found in the filing text

Share repurchase amount · consolidated · program period$600M
Read the original on SEC EDGAR ↗

JBS N.V. — questions

What did JBS N.V. file recently?
26 SEC filings in the last 12 months. Latest: 8-K on 2026-09-15 — JBS N.V. filed an 8-K with only Item 9.01 (financial statements and exhibits) and no substantive Item 8.01 disclosure. The filing contains only a cover page exhibit. No material event.

Every figure on this page comes from JBS N.V.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.